Anthem Blue Cross Connecticut Commercial Clinical Policy

Anthem Blue Cross Connecticut GENE.00010 Panel and other Multi-Gene Testing for Polymorphisms to Determine Drug-Metabolizer Status Form

Effective Date

12/28/2023

Last Reviewed

05/11/2023

Original Document

  Reference



This document addresses the use of panel and multi-gene tests for polymorphisms to determine drug-metabolizer status.

Note: For additional information regarding single (individual) gene tests for polymorphisms, please see:

  • CG-GENE-11 Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer Status

Note: For additional information regarding panel tests please see:

  • GENE.00052 Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling

Position Statement

Investigational and Not Medically Necessary:

The use of panel and multi-gene tests for polymorphisms to determine drug-metabolizer status is considered investigational and not medically necessary.

Want to learn more?